En esta página
01SPRY precio
02Instantánea
03Gráfico
05Acerca de
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
SPRY ARS Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 13, 2026
$4,07
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$3,99mínimo 52 semanas
$13,15máximo 52 semanas
Capitalización Bursátil (MRQ)
$405M
P/E (TTM)
-1.9
BPA (TTM)
$-2.17
Ingresos (TTM)
$117M
tus insignias
Rango 52S
$4–$13
Calificación del Analista
STRONG BUY
Precio Objetivo
$22
P/E
-1.9
ROE
-210.3%
Margen de Beneficio Neto
-184.2%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
SPRY Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$4.07
Capitalización Bursátil (MRQ)
$405M
P/E (TTM)
-1.9
BPA (TTM)
$-2.17
Ingresos (TTM)
$117M
ROE (TTM)
-210.3%
Rango 52S
$4–$13
SPRY Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Acerca de ARS Pharmaceuticals, Inc. - Common Stock Descripción general de la empresa de Wikipedia
sectorHealthcare
industriaBiotechnology
empleados195
paísUS
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$84M2021-12-31 → 2025-12-31
BPA$-1.742021-12-31 → 2025-12-31
Flujo de caja libre$-171M2021-12-31 → 2025-12-31
Margen neto-184.2%2021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | SPRY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -1.9promedio 5A ≈19.2 | ≈19.2 | · | · | |
| P/S (TTM) | 3.5promedio 5A ≈3657.7 | ≈3657.7 | · | · | |
| P/C (MRQ) | 32.3promedio 5A ≈4.0 | ≈4.0 | 3.1 | Sobrevalorado | |
| Precio / FCF (TTM) | -2.1promedio 5A ≈8.1 | ≈8.1 | · | · | |
| Precio / Flujo de Caja (TTM) | -2.1promedio 5A ≈7.4 | ≈7.4 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | -291.6promedio 5A ≈5.2 | ≈5.2 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | SPRY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -185.0%promedio 5A ≈-62499.0% | ≈-62499.0% | -115.0% | Débil | |
| EBITDA Margin (Margen EBITDA) | -212.9%promedio 5A ≈-62494.2% | ≈-62494.2% | -115.0% | Débil | |
| Pretax Margin (Margen antes de impuestos) | -203.4% | · | · | · | |
| Margen de Beneficio Neto (TTM) | -184.2%promedio 5A ≈-53691.9% | ≈-53691.9% | -107.0% | Débil | |
| ROA (TTM) | -76.5%promedio 5A ≈-22.7% | ≈-22.7% | -50.5% | En línea | |
| ROE (TTM) | -210.3%promedio 5A ≈-38.1% | ≈-38.1% | -77.4% | Débil | |
| ROIC | -157.0% | · | -61.4% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | SPRY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 3.5promedio 5A ≈37.4 | ≈37.4 | 9.4 | Baja liquidez | |
| Ratio Rápido (MRQ) | 3.1promedio 5A ≈36.7 | ≈36.7 | 7.7 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | SPRY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -5.5%promedio 5A ≈74221.0% | ≈74221.0% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 300.1% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | SPRY | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.2promedio 5A ≈0.1 | ≈0.1 | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 5.0 | · | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$432.2K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-5.9%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 13, 2026 | $-0.63 | $-0.50 | -25.4% |
| 31 de marzo de 2026 | May 15, 2026 | $-0.61 | $-0.54 | -13.8% |
| 31 de diciembre de 2025 | $-0.42 | $-0.45 | 6.8% | |
| 30 de septiembre de 2025 | $-0.52 | $-0.48 | -8.0% | |
| 30 de junio de 2025 | $-0.46 | $-0.48 | 4.0% | |
| 31 de marzo de 2025 | $-0.35 | $-0.35 | 1.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $84M | $89M | $30.0K | $1M | $6M | |
| Cost of Revenue | · | · | $0 | · | · | |
| R&D Expense | $13M | $20M | $20M | $18M | $20M | |
| SG&A Expense | $230M | $72M | $47M | $603.0K | $5M | |
| Operating Expenses | $264M | $92M | $68M | $37M | $25M | |
| Operating Income | $-179M | $-3M | $-68M | $-36M | $-19M | |
| Other Non-op | $8M | $11M | $13M | $974.0K | $-789.0K | |
| Pretax Income | $-171M | $8M | $-54M | · | · | |
| Income Tax | $-80.0K | $288.0K | $0 | $0 | $0 | |
| Net Income | $-171M | $8M | $-54M | $-35M | $-20M | |
| EPS (Basic) | $-1.74 | $0.08 | $-0.57 | $-0.87 | $-0.70 | |
| EPS (Diluted) | $-1.74 | $0.08 | $-0.57 | $-0.87 | $-0.70 | |
| Shares (Basic) | 98,566,481 | 96,936,661 | 95,215,322 | 39,956,043 | 28,872,242 | |
| Shares (Diluted) | 98,566,481 | 102,390,828 | 95,215,322 | 39,956,043 | 28,872,242 | |
| EBITDA | $-179M | $-3M | $-68M | $-35M | $-90M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $51M | $71M | $211M | $60M | |
| Short-term Investments | $204M | $263M | $157M | $64M | $0 | |
| Receivables | $25M | $8M | $0 | · | · | |
| Inventory | $31M | $11M | $0 | · | · | |
| Prepaid Expense | $6M | $7M | $3M | $3M | $667.0K | |
| Current Assets | $285M | $334M | $232M | $278M | $61M | |
| PP&E (Net) | $2M | $1M | $574.0K | $329.0K | $72.0K | |
| PP&E (Gross) | · | · | $695.0K | $377.0K | $86.0K | |
| Accum. Depreciation | · | $200.0K | $121.0K | $48.0K | $14.0K | |
| Intangibles | $14M | $7M | $0 | · | · | |
| Other Non-current Assets | · | · | · | $0 | · | |
| Total Assets | $328M | $351M | $233M | $281M | $61M | |
| Accounts Payable | $6M | $10M | $759.0K | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | $12M | |
| Short-term Debt | · | · | · | $0 | $3M | |
| Current Liabilities | $39M | $23M | $2M | $5M | $8M | |
| Capital Leases | · | $0 | $37.0K | $251.0K | $480.0K | |
| Total Liabilities | $213M | $94M | $2M | $9M | $17M | |
| Long-term Debt | $96M | $0 | · | · | · | |
| Total Debt | · | · | · | $0 | · | |
| Common Stock | $10.0K | $10.0K | $10.0K | $9.0K | $3.0K | |
| Paid-in Capital | $409M | $380M | $362M | $349M | $11M | |
| Retained Earnings | $-295M | $-123M | $-131M | $-77M | $-42M | |
| AOCI | $125.0K | $220.0K | $49.0K | $407.0K | $0 | |
| Stockholders' Equity | $114M | $257M | $231M | $273M | $-31M | |
| Liabilities + Equity | $328M | $351M | $233M | $281M | $61M | |
| Shares Outstanding | 99,290,926 | 97,954,172 | 96,414,963 | 93,943,316 | 30,369,413 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $1M | $79.0K | $100.0K | $319.0K | $213.0K | |
| Stock-based Comp | $22M | $15M | $9M | $6M | $3M | |
| Deferred Tax | $0 | $0 | $0 | · | · | |
| Amort. of Intangibles | $800.0K | $100.0K | · | · | · | |
| Other Non-cash | · | · | · | $-12M | · | |
| Operating Cash Flow | $-171M | $14M | $-59M | $-40M | $-18M | |
| CapEx | $339.0K | $563.0K | $175.0K | $199.0K | $55.0K | |
| Investing Cash Flow | $57M | $-106M | $-87M | $-199.0K | $-55.0K | |
| Financing Cash Flow | $105M | $72M | $7M | $191M | $53M | |
| Net Change in Cash | $-10M | $-20M | $-140M | $150M | $36M | |
| Taxes Paid | $200.0K | · | · | · | · | |
| Free Cash Flow | $-171M | $13M | $-59M | $-40M | $-68M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -212.9% | -3.5% | -225066.7% | -2698.8% | -84513.2% | |
| Net Margin | -203.3% | 9.0% | -181216.7% | -2635.4% | -84413.2% | |
| Pretax Margin | -203.4% | 9.3% | · | · | · | |
| EBITDA Margin | -212.9% | -3.5% | -225066.7% | -2674.5% | -84513.2% | |
| ROA | -50.5% | 2.7% | -21.1% | -20.2% | -24.6% | |
| ROE | -111.8% | 3.5% | -23.2% | -31.1% | -27.7% | |
| ROIC | -157.0% | -1.2% | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | 14.3 | 96.9 | 51.0 | 17.6 | |
| Quick Ratio | 6.9 | 13.7 | 95.5 | 50.4 | 17.1 | |
| Debt / Equity | · | · | · | 0.0 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 5.0 | 21.8 | · | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $1.15 | $2.62 | $2.39 | $2.90 | $8.94 | |
| Revenue / Share | $0.85 | $0.87 | $0.00 | $0.03 | · | |
| Cash Flow / Share | $-1.73 | $0.13 | $-0.62 | $-1.00 | · | |
| Cash / Share | $0.42 | $0.52 | $0.74 | $2.24 | $7.24 | |
| EPS (TTM) | $-1.74 | $0.08 | $-0.57 | $-0.87 | $-0.70 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | -5.5% | 297063.3% | -97.7% | -76.1% | · | |
| Revenue CAGR 3Y | 300.1% | 153.0% | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $84M | $89M | $30.0K | $1M | $6M | |
| Net Income TTM | $-171M | $8M | $-54M | $-35M | $-20M | |
| Market Cap | $1.16B | $1.03B | $528M | $801M | $234M | |
| Enterprise Value | · | · | · | $527M | · | |
| P/E | -6.7 | 131.9 | -9.6 | -9.8 | -9.5 | |
| P/S | 13.7 | 11.6 | 17611.8 | 608.9 | 42.5 | |
| P/B | 10.1 | 4.0 | 2.3 | 2.9 | 0.7 | |
| P / Tangible Book | 11.6 | 4.1 | 2.3 | 2.9 | · | |
| P / Cash Flow | -6.8 | 76.3 | -8.9 | -20.0 | -3.5 | |
| P / FCF | -6.8 | 79.6 | -8.9 | -19.9 | -3.4 | |
| EV / EBITDA | · | · | · | -15.0 | · | |
| EV / FCF | · | · | · | -13.1 | · | |
| EV / Revenue | · | · | · | 400.4 | · | |
| Earnings Yield | -14.9% | 0.76% | -10.4% | -10.2% | -10.5% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34M | $23M | $28M | $33M | $16M | $8M | $87M | $2M | $500.0K | $0 | $0 | $0 | $10.0K | $20.0K | $0 | $189.0K | |
| R&D Expense | $5M | $4M | $3M | $3M | $4M | $3M | $3M | $4M | $7M | $5M | $3M | $3M | $7M | $7M | $5M | $4M | |
| SG&A Expense | $78M | $72M | $60M | $75M | $54M | $41M | $35M | $19M | $9M | $8M | $32M | $15M | $181.0K | $337.0K | $-7M | $3M | |
| Operating Expenses | $95M | $83M | $70M | $86M | $63M | $45M | $39M | $24M | $16M | $13M | $10M | $18M | $21M | $19M | $15M | $7M | |
| Operating Income | $-61M | $-60M | $-41M | $-53M | $-48M | $-37M | $47M | $-22M | $-15M | $-13M | $-10M | $-18M | $-21M | $-19M | $-15M | $-7M | |
| Other Non-op | $-874.0K | $-473.0K | $61.0K | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $1M | $47.0K | |
| Net Income | $-62M | $-61M | $-41M | $-51M | $-45M | $-34M | $50M | $-19M | $-13M | $-10M | $-7M | $-15M | $-17M | $-15M | $-14M | $-7M | |
| EPS (Basic) | $-0.63 | $-0.61 | $-0.41 | $-0.52 | $-0.46 | $-0.35 | $0.52 | $-0.20 | $-0.13 | $-0.11 | $-0.07 | $-0.16 | $-0.18 | $-0.16 | $-0.21 | $-0.21 | |
| EPS (Diluted) | $-0.63 | $-0.61 | $-0.41 | $-0.52 | $-0.46 | $-0.35 | $0.52 | $-0.20 | $-0.13 | $-0.11 | $-0.07 | $-0.16 | $-0.18 | $-0.16 | $-0.21 | $-0.21 | |
| Shares (Basic) | 99,312,526 | 99,296,408 | · | 98,807,600 | 98,361,771 | 98,060,636 | · | 97,032,331 | 96,827,687 | 96,486,480 | · | 95,576,627 | 94,911,268 | 94,227,313 | · | 30,755,123 | |
| Shares (Diluted) | 99,312,526 | 99,296,408 | · | 98,807,600 | 98,361,771 | 98,060,636 | · | 97,032,331 | 96,827,687 | 96,486,480 | · | 95,576,627 | 94,911,268 | 94,227,313 | · | 30,755,123 | |
| EBITDA | $-61M | · | · | $-53M | $-48M | $-37M | · | · | $-15M | $-13M | · | $-18M | $-21M | $-19M | · | $-19M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $24M | $41M | $60M | $52M | $40M | $51M | $40M | $37M | $56M | $71M | $61M | $119M | $88M | $211M | $203M | |
| Short-term Investments | $136M | $177M | $204M | $229M | $189M | $236M | $263M | $165M | $182M | $168M | $157M | $181M | $133M | $177M | $64M | $63M | |
| Receivables | $47M | $29M | $25M | $36M | $25M | $9M | $8M | $773.0K | · | · | $0 | · | · | · | · | · | |
| Inventory | $31M | $32M | $31M | $21M | $22M | $7M | $11M | $715.0K | · | · | $0 | · | · | · | · | · | |
| Prepaid Expense | $9M | $7M | $6M | $6M | $7M | $12M | $7M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | |
| Current Assets | $212M | $245M | $285M | $339M | $281M | $304M | $334M | $209M | $221M | $226M | $232M | $244M | $255M | $267M | $278M | $271M | |
| PP&E (Net) | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $843.0K | $636.0K | $616.0K | $574.0K | $617.0K | $594.0K | $584.0K | $329.0K | $15.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | $748.0K | · | $726.0K | $682.0K | $652.0K | $377.0K | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | $171.0K | $150.0K | $132.0K | $121.0K | $109.0K | $88.0K | $68.0K | $48.0K | · | |
| Intangibles | $14M | $14M | $14M | $15M | $13M | $7M | $7M | $8M | · | · | $0 | · | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $690.0K | $138.0K | · | · | · | |
| Total Assets | $249M | $288M | $328M | $373M | $313M | $327M | $351M | $218M | $222M | $228M | $233M | $249M | $259M | $271M | $281M | $271M | |
| Accounts Payable | $5M | $5M | $6M | $8M | $16M | $4M | $10M | $8M | $3M | $839.0K | $759.0K | $3M | $2M | $3M | $2M | $126.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Current Liabilities | $61M | $50M | $39M | $51M | $46M | $28M | $23M | $17M | $7M | $4M | $2M | $11M | $10M | $10M | $5M | $4M | |
| Capital Leases | · | · | · | $949.0K | $1M | · | · | $0 | $0 | $0 | $37.0K | $92.0K | $146.0K | $199.0K | $251.0K | $0 | |
| Total Liabilities | $237M | $226M | $213M | $225M | $121M | $98M | $94M | $17M | $7M | $4M | $2M | $11M | $10M | $10M | $9M | $4M | |
| Long-term Debt | $97M | $97M | $96M | $96M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Common Stock | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $4.0K | |
| Paid-in Capital | $430M | $417M | $409M | $401M | $394M | $386M | $380M | $374M | $369M | $366M | $362M | $362M | $358M | $353M | $349M | $517M | |
| Retained Earnings | $-418M | $-355M | $-295M | $-253M | $-202M | $-157M | $-123M | $-173M | $-154M | $-142M | $-131M | $-124M | $-109M | $-92M | $-77M | $-248M | |
| AOCI | $-140.0K | $-96.0K | $125.0K | $-7.0K | $-46.0K | $72.0K | $220.0K | $339.0K | $-145.0K | $-124.0K | $49.0K | $-161.0K | $-180.0K | $68.0K | $407.0K | $-2M | |
| Stockholders' Equity | $13M | $61M | $114M | $148M | $192M | $229M | $257M | $201M | $215M | $224M | $231M | $237M | $249M | $261M | $273M | $267M | |
| Liabilities + Equity | $249M | $288M | $328M | $373M | $313M | $327M | $351M | $218M | $222M | $228M | $233M | $249M | $259M | $271M | $281M | $271M | |
| Shares Outstanding | 99,437,865 | 99,300,137 | 99,290,926 | 98,844,178 | 98,697,658 | 98,129,804 | 97,954,172 | 97,147,442 | 96,939,797 | 96,574,049 | 96,414,963 | 95,796,254 | 95,322,953 | 94,448,028 | 93,943,316 | 35,882,653 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $416.0K | $397.0K | $417.0K | $391.0K | $279.0K | $280.0K | $29.0K | $100.0K | $18.0K | $11.0K | $0 | $100.0K | · | · | · | · | |
| Stock-based Comp | $12M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $3M | $3M | $2M | $3M | $2M | $2M | $5M | $-9M | |
| Amort. of Intangibles | $300.0K | $300.0K | $499.9K | $200.0K | $100.0K | $100.0K | $100.0K | $0 | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $-61M | $-45M | $-43M | $-47M | $-40M | $-41M | $42M | $-14M | $-7M | $-7M | $-17M | $-13M | $-17M | $-12M | $-20M | $15M | |
| CapEx | $0 | $0 | $0 | $197.0K | $51.0K | $91.0K | $302.0K | $140.0K | $38.0K | $83.0K | $-91.0K | $43.0K | $30.0K | $193.0K | $126.0K | $-545.0K | |
| Investing Cash Flow | $42M | $28M | $24M | $-45M | $49M | $29M | $-102M | $17M | $-13M | $-9M | $26M | $-47M | $45M | $-112M | $-126.0K | $545.0K | |
| Financing Cash Flow | $3M | $159.0K | $1M | $100M | $3M | $725.0K | $71M | $680.0K | $545.0K | $258.0K | $2M | $921.0K | $3M | $1M | $194M | $-3M | |
| Net Change in Cash | $-16M | $-17M | $-18M | $8M | $12M | $-11M | $11M | $3M | $-19M | $-15M | $10M | $-58M | $31M | $-123M | $173M | $-7M | |
| Free Cash Flow | · | · | · | · | · | $-41M | · | · | · | $-7M | · | · | · | $-13M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -182.6% | · | · | -163.7% | -302.9% | -466.3% | · | · | -3068.0% | · | · | · | -206030.0% | -93565.0% | · | -1761.8% | |
| Net Margin | -185.2% | · | · | -157.4% | -285.6% | -425.7% | · | · | -2503.2% | · | · | · | -173700.0% | -74805.0% | · | -1661.8% | |
| EBITDA Margin | -182.6% | · | · | -163.7% | -302.9% | -466.3% | · | · | -3068.0% | · | · | · | -206030.0% | -93565.0% | · | -1761.8% | |
| ROA | -22.1% | · | · | -17.3% | -16.8% | -12.2% | · | · | -5.2% | -4.1% | · | -5.7% | -6.3% | -5.1% | · | -5.7% | |
| ROE | -60.9% | · | · | -29.3% | -22.0% | -15.0% | · | · | -5.4% | -4.2% | · | -5.9% | -6.6% | -5.4% | · | -6.0% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | · | · | 6.7 | 6.2 | 11.0 | · | · | 32.8 | 60.9 | · | 21.9 | 25.4 | 27.2 | · | 67.9 | |
| Quick Ratio | 3.1 | · | · | 6.4 | 5.8 | 10.3 | · | · | 32.5 | 60.2 | · | 21.6 | 25.1 | 26.9 | · | 66.8 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.1 | 0.1 | 0.0 | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 0.9 | · | · | 1.7 | 1.3 | 1.7 | · | · | · | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.13 | · | · | $1.49 | $1.95 | $2.33 | · | · | $2.22 | $2.32 | · | $2.48 | $2.61 | $2.77 | · | $7.44 | |
| Revenue / Share | $0.34 | · | · | $0.33 | $0.16 | $0.08 | · | · | $0.01 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.03 | |
| Cash Flow / Share | · | · | · | · | · | $-0.42 | · | · | · | $-0.07 | · | · | · | $-0.13 | · | · | |
| Cash / Share | $0.08 | · | · | $0.60 | $0.52 | $0.41 | · | · | $0.38 | $0.58 | · | $0.63 | $1.25 | $0.93 | · | $5.66 | |
| EPS (TTM) | $-2.17 | $-1.94 | · | $-0.81 | $-0.49 | $-0.16 | · | $-0.60 | $-0.47 | $-0.52 | · | $-0.71 | $-0.76 | $-0.79 | · | $0.53 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $79M | · | $143M | $112M | $97M | · | $3M | $500.0K | $10.0K | · | $30.0K | $219.0K | $673.0K | · | · | |
| Net Income TTM | $-215M | $-191M | · | $-80M | $-48M | $-16M | · | $-57M | $-45M | $-50M | · | $-62M | $-53M | $-42M | · | $26M | |
| Market Cap | $796M | · | · | $993M | $1.72B | $1.23B | · | · | $825M | $987M | · | $362M | $639M | $615M | · | $189M | |
| P/E | -3.7 | -4.1 | · | -12.4 | -35.6 | -78.6 | · | -24.2 | -18.1 | -19.7 | · | -5.3 | -8.8 | -8.2 | · | 10.0 | |
| P/S | 6.8 | · | · | 7.0 | 15.3 | 12.7 | · | · | 1649.9 | 98698.7 | · | 12070.3 | 2916.3 | 913.6 | · | · | |
| P/B | 63.7 | · | · | 6.7 | 9.0 | 5.4 | · | · | 3.8 | 4.4 | · | 1.5 | 2.6 | 2.4 | · | 0.7 | |
| P / Tangible Book | · | 16.9 | · | 7.5 | 9.6 | 5.6 | · | 7.3 | 3.8 | 4.4 | · | 1.5 | 2.6 | 2.4 | · | 0.7 | |
| P / Cash Flow | · | · | · | · | · | -30.3 | · | · | · | -147.1 | · | · | · | -49.5 | · | · | |
| Earnings Yield | -27.1% | -24.2% | · | -8.1% | -2.8% | -1.3% | · | -4.1% | -5.5% | -5.1% | · | -18.8% | -11.3% | -12.1% | · | 10.0% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $84M | $89M | $30.0K | $1M | $6M |
| Margen Operativo % | -212.9% | -3.5% | -225066.7% | -2698.8% | -84513.2% |
| Beneficio neto | $-171M | $8M | $-54M | $-35M | $-20M |
| EPS Diluido | $-1.74 | $0.08 | $-0.57 | $-0.87 | $-0.70 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | · | · | · | 0.0 | · |
| Ratio corriente | 7.3 | 14.3 | 96.9 | 51.0 | 17.6 |
| Ratio Rápido | 6.9 | 13.7 | 95.5 | 50.4 | 17.1 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-171M | $13M | $-59M | $-40M | $-68M |
Propietarios institucionales (13F) 222 declarantes · $746.7M total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
222
Valor en tenencia
$746.7M
Nuevas posiciones
38
Posiciones cerradas
30
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 38 (-5 vs trimestre anterior) | 30 (+7 vs trimestre anterior) | 73 (+10 vs trimestre anterior) | 56 (0 vs trimestre anterior) | -4.1M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $86 996 426 | 10 860 977 | 11,65% | Acciones |
| Rubric Capital Management LP | $68 412 297 | 8 540 861 | 9,16% | Acciones |
| ORBIMED ADVISORS LLC | $66 390 965 | 8 288 510 | 8,89% | Acciones |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $60 105 534 | 7 503 812 | 8,05% | Acciones |
| BlackRock, Inc. | $42 543 666 | 5 311 319 | 5,70% | Acciones |
| VANGUARD GROUP INC | $40 881 877 | 3 509 174 | 5,48% | Acciones |
| Tyro Capital Management LLC | $35 719 289 | 4 459 337 | 4,78% | Acciones |
| Aberdeen Group plc | $33 406 738 | 4 170 629 | 4,47% | Acciones |
| SR One Capital Management, LP | $32 143 353 | 4 012 903 | 4,30% | Acciones |
| STATE STREET CORP | $29 882 290 | 3 730 623 | 4,00% | Acciones |
| Capital World Investors | $22 066 997 | 2 754 931 | 2,96% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $20 453 759 | 2 553 528 | 2,74% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $19 231 505 | 2 400 937 | 2,58% | Acciones |
| UBS Group AG | $15 536 629 | 1 939 654 | 2,08% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $13 612 279 | 1 699 017 | 1,82% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $12 828 047 | 1 601 504 | 1,72% | Acciones |
| GENERAL AMERICAN INVESTORS CO INC | $9 075 698 | 1 133 046 | 1,22% | Acciones |
| Third Point LLC | $8 010 000 | 1 000 000 | 1,07% | Acciones |
| PEREGRINE CAPITAL MANAGEMENT LLC | $5 383 833 | 672 139 | 0,72% | Acciones |
| Tejara Capital Ltd | $4 862 382 | 607 039 | 0,65% | Acciones |
| ADAR1 Capital Management, LLC | $4 814 002 | 600 999 | 0,64% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4 540 300 | 566 829 | 0,61% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 416 842 | 551 416 | 0,59% | Acciones |
| NORTHERN TRUST CORP | $4 398 003 | 549 064 | 0,59% | Acciones |
| LEVIN CAPITAL STRATEGIES, L.P. | $4 397 210 | 548 965 | 0,59% | Acciones |
| CITADEL ADVISORS LLC | $4 253 814 | 531 063 | 0,57% | Acciones |
| Empire Life Investments Inc. | $3 779 567 | 471 856 | 0,51% | Acciones |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $3 731 388 | 464 681 | 0,50% | Acciones |
| BANK OF AMERICA CORP /DE/ | $3 710 681 | 463 256 | 0,50% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $3 692 618 | 461 001 | 0,49% | Acciones |
| FIL Ltd | $3 649 156 | 455 575 | 0,49% | Acciones |
| JPMORGAN CHASE & CO | $3 109 986 | 363 316 | 0,42% | Acciones |
| GOLDMAN SACHS GROUP INC | $3 049 967 | 380 770 | 0,41% | Acciones |
| Eversept Partners, LP | $3 019 826 | 377 007 | 0,40% | Acciones |
| K2 PRINCIPAL FUND, L.P. | $3 004 807 | 375 132 | 0,40% | Acciones |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | $2 991 663 | 373 491 | 0,40% | Acciones |
| FMR LLC | $2 796 806 | 349 164 | 0,37% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $2 551 850 | 318 583 | 0,34% | Acciones |
| Trexquant Investment LP | $2 296 731 | 286 733 | 0,31% | Acciones |
| Jump Financial, LLC | $2 044 152 | 255 200 | 0,27% | Acciones |
| MORGAN STANLEY | $1 835 091 | 229 100 | 0,25% | Acciones |
| FAS Wealth Partners, Inc. | $1 718 202 | 214 507 | 0,23% | Acciones |
| Quinn Opportunity Partners LLC | $1 401 750 | 175 000 | 0,19% | Acciones |
| Bank of New York Mellon Corp | $1 346 769 | 168 136 | 0,18% | Acciones |
| DAFNA Capital Management LLC | $1 315 923 | 164 285 | 0,18% | Acciones |
| Nuveen, LLC | $1 292 350 | 161 342 | 0,17% | Acciones |
| Ishara Investments LP | $1 149 355 | 143 490 | 0,15% | Acciones |
| Engineers Gate Manager LP | $1 116 746 | 139 419 | 0,15% | Acciones |
| Steward Partners Investment Advisory, LLC | $1 030 086 | 128 600 | 0,14% | Acciones |
| BARCLAYS PLC | $1 011 352 | 126 261 | 0,14% | Acciones |
Activistas y propietarios del %+ 5 8 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×4 presentaciones | 1 de octubre de 2025 | 11,10% | Enmienda | · | SEC |
| Deerfield Mgmt III, L.P., Deerfield Private Design Fund III, L.P., Deerfield Mgmt IV, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Management Company, L.P., James E. Flynn ×5 presentaciones | 1 de agosto de 2025 | 7,75% | Enmienda | · | SEC |
| The Pratik Shah Living Trust dated June 15, 2011(1) ×3 presentaciones | 17 de junio de 2024 | · | Presentación inicial | · | SEC |
| Robert G. Bell ×2 presentaciones | 1 de septiembre de 2023 | · | Presentación inicial | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital LLC ×2 presentaciones | 30 de noviembre de 2022 | · | Presentación inicial | · | SEC |
| Richard E. Lowenthal, M.S., MSEL | 18 de noviembre de 2022 | · | Presentación inicial | · | SEC |
| Sarina Tanimoto, M.D., M.B.A. | 18 de noviembre de 2022 | · | Presentación inicial | · | SEC |
| U.S. Venture Partners XII, L.P. (“USVP XII”), U.S. Venture Partners XII-A, L.P. (“USVP XII-A”), Presidio Management Group XII, L.L.C. (“PMG XII”), Casey M. Tansey, Jonathan D. Root ×2 presentaciones | 27 de enero de 2022 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 28 insiders · 11 directivos · 14 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Kathleen D. Scott | Chief Financial Officer | 2 de enero de 2026 A | 10 042 | 0 | 0 | $0 |
| Jonathan Piazza | Chief Financial Officer | 2 de mayo de 2022 A | 69 225 | 0 | 0 | $0 |
| Donn Casale | President | 1 de julio de 2026 A | · | 0 | 0 | $0 |
| Valerie Odegard | President and CSO | 2 de mayo de 2022 A | 61 639 | 0 | 0 | $0 |
| Margaret Ekins Smith | Chief Commercial Officer | 1 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Eric Karas | Chief Commercial Officer | 12 de junio de 2026 M | 12 176 | 0 | 1 | $-250 000 |
| Alexander A Fitzpatrick | Chief Legal Officer | 12 de junio de 2026 S | 90 910 | 0 | 1 | $-33 550 |
| Sarina Tanimoto | CHIEF MEDICAL OFFICER | 2 de enero de 2026 A | 1 247 447 | 0 | 0 | $0 |
| Justin Chakma | Chief Business Officer | 2 de enero de 2026 A | 0 | 0 | 2 | $-1 475 627 |
| Naomi Hunder | Chief Medical Officer | 2 de mayo de 2022 A | 54 427 | 0 | 0 | $0 |
| Russ Hawkinson | Sr. Vice President of Finance | 2 de mayo de 2022 A | 37 251 | 0 | 0 | $0 |
| Michael Kelly | Consejero | 24 de junio de 2026 A | 83 225 | 0 | 0 | $0 |
| Rajeev Dadoo | Consejero | 24 de junio de 2026 A | 3 009 677 | 0 | 0 | $0 |
| Pratik Shah | Consejero | 24 de junio de 2026 A | 4 474 554 | 0 | 0 | $0 |
| Saqib Islam | Consejero | 24 de junio de 2026 A | · | 0 | 0 | $0 |
| Laura Shawver | Consejero | 24 de junio de 2026 A | 210 346 | 0 | 0 | $0 |
| Peter A. Thompson | Consejero | 24 de junio de 2026 A | 0 | 0 | 0 | $0 |
| Brent L Saunders | Consejero | 24 de junio de 2026 A | 0 | 0 | 0 | $0 |
| Phillip M Schneider | Consejero | 24 de junio de 2026 A | · | 0 | 0 | $0 |
| Maria Koehler | Consejero | 10 de junio de 2022 A | · | 0 | 0 | $0 |
| Andrew Kenneth William Powell | Consejero | 10 de junio de 2022 A | · | 0 | 0 | $0 |
| Robert Hershberg | Consejero | 10 de junio de 2022 A | · | 0 | 0 | $0 |
| Vickie L Capps | Consejero | 10 de junio de 2022 A | 61 576 | 0 | 0 | $0 |
| Jonathan D Root | Consejero | 10 de junio de 2022 A | 2 364 | 0 | 0 | $0 |
| Thilo Schroeder | Consejero | 8 de diciembre de 2020 C | 1 910 029 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | Propietario del 10% | 8 de diciembre de 2020 C | 699 412 | 0 | 0 | $0 |
| Brian Dorsey | · | 2 de enero de 2026 A | 10 789 | 0 | 1 | $-190 122 |
| Richard E Lowenthal | · | 2 de enero de 2026 A | 1 196 494 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 23 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| LABU · Direxion Shares ETF Trust | 0,08% | 77 714 NS | 31 de julio de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,05% | 3 668 NS | 31 de julio de 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 66 043 SH | 19 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 7 035 SH | 1 de octubre de 2026 | Diario |
| IBB · iShares Trust | 0,02% | 471 221 SH | 11 de septiembre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,02% | 1 062 NS | 31 de julio de 2026 | N-PORT |
| IWO · iShares Trust | 0,02% | 578 426 SH | 11 de septiembre de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 1 579 276 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 29 426 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 745 809 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 354 157 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 142 140 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,00% | 22 392 NS | 31 de julio de 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 2 851 SH | 10 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 39 569 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 2 672 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 81 645 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 17 862 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 749 763 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 489 SH | 19 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 2 495 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 13 569 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 52 056 SH | 11 de septiembre de 2026 | Diario |
SPRY Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 10 analistas
COMPRA
Objetivo mediano
$22.50
+452,8%
5 50,0%
Compra fuerte
4 40,0%
Compra
1 10,0%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
4 analistas · 2026-10-02Objetivo medio $22.50 +452,8%
← Por Debajo de Todos los Objetivos
Precio Actual $4.07
Mín$15.00
Media$22.50
Máx$30.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | · |
| DMAC | $428M | · | · | · | -78.7% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | · |
| EIKN | · | · | · | · | · | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| GALT | $271M | -8.7 | · | · | 25.0% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 13, 2026